Clinical Effectiveness of Renal Transplant Outpatient Pharmaceutical Care Services in Korea.
clinical effectiveness
kidney transplant
outpatient clinic
pharmaceutical care service
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
21 Sep 2023
21 Sep 2023
Historique:
received:
18
08
2023
revised:
18
09
2023
accepted:
20
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
The necessity and importance of pharmaceutical care services (PCS) are well recognized, yet the concept and scope of PCS have not yet been clearly defined in Korea, particularly in kidney transplantation outpatient clinics. The main purpose of this study is to evaluate whether PCS is effective in the outpatient setting for kidney transplant patients. For three years, a clinical pharmacist provided PCS to kidney transplant patients in an outpatient setting to evaluate the clinical effectiveness of PCS. A total of 302 patients were matched in a 1:1 ratio, with 151 in the PCS group and 151 in the control group. These patients were followed, and a total of 476 interventions were provided to them, including medication reconciliation (n = 113, 23.7%), medication evaluation and management (n = 186, 39.1%), and pharmaceutical care transition (n = 177, 37.2%) services. The estimated glomerular filtration rate (eGFR) exhibited a notable difference between the control and PCS groups when comparing the pre- and post-study periods measurements. In the control group, there was a decline of 7.0 mL/min/1.73 m Our study highlights the promising potential of PCS implementation in kidney transplantation outpatient clinics. Further research is needed to validate and expand upon these findings, especially in diverse clinical settings.
Sections du résumé
BACKGROUND
BACKGROUND
The necessity and importance of pharmaceutical care services (PCS) are well recognized, yet the concept and scope of PCS have not yet been clearly defined in Korea, particularly in kidney transplantation outpatient clinics.
AIM
OBJECTIVE
The main purpose of this study is to evaluate whether PCS is effective in the outpatient setting for kidney transplant patients.
METHODS
METHODS
For three years, a clinical pharmacist provided PCS to kidney transplant patients in an outpatient setting to evaluate the clinical effectiveness of PCS.
RESULTS
RESULTS
A total of 302 patients were matched in a 1:1 ratio, with 151 in the PCS group and 151 in the control group. These patients were followed, and a total of 476 interventions were provided to them, including medication reconciliation (n = 113, 23.7%), medication evaluation and management (n = 186, 39.1%), and pharmaceutical care transition (n = 177, 37.2%) services. The estimated glomerular filtration rate (eGFR) exhibited a notable difference between the control and PCS groups when comparing the pre- and post-study periods measurements. In the control group, there was a decline of 7.0 mL/min/1.73 m
CONCLUSION
CONCLUSIONS
Our study highlights the promising potential of PCS implementation in kidney transplantation outpatient clinics. Further research is needed to validate and expand upon these findings, especially in diverse clinical settings.
Identifiants
pubmed: 37761794
pii: healthcare11182597
doi: 10.3390/healthcare11182597
pmc: PMC10531252
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministry of Food and Drug Safety
ID : 22183MFDS499
Références
Clin Exp Nephrol. 2019 Apr;23(4):484-492
pubmed: 30341572
J Manag Care Spec Pharm. 2018 Feb;24(2):173-181
pubmed: 29384023
Int J Med Sci. 2021 Mar 3;18(9):1975-1979
pubmed: 33850467
Pharmaceutics. 2022 Feb 08;14(2):
pubmed: 35214111
Scand J Infect Dis. 2013 Dec;45(12):891-9
pubmed: 24024759
Can J Diabetes. 2017 Dec;41(6):580-586
pubmed: 28965748
Ann Pharmacother. 2000 May;34(5):567-72
pubmed: 10852081
Saudi J Kidney Dis Transpl. 2017 Nov-Dec;28(6):1293-1306
pubmed: 29265040
Diabetes Res Clin Pract. 2012 Aug;97(2):223-30
pubmed: 22541634
Am J Kidney Dis. 2012 Sep;60(3):371-9
pubmed: 22633556
Drug Metab Dispos. 1995 Dec;23(12):1315-24
pubmed: 8689938
Am J Kidney Dis. 2020 Apr;75(4):497-507
pubmed: 31606235
PLoS One. 2018 Sep 28;13(9):e0201705
pubmed: 30265678
Arch Intern Med. 1999 Nov 22;159(21):2553-60
pubmed: 10573045
Patient Prefer Adherence. 2008 Feb 02;2:287-92
pubmed: 19920975
BMC Fam Pract. 2013 Jul 13;14:96
pubmed: 23849005
Int J Qual Health Care. 2003 Dec;15 Suppl 1:i49-59
pubmed: 14660523
Ann Intern Med. 1966 Oct;65(4):629-40
pubmed: 5926386
Int J Clin Pharm. 2013 Apr;35(2):260-7
pubmed: 23277421
Am J Kidney Dis. 2017 Sep;70(3):386-396
pubmed: 28663062
Int J Clin Pharm. 2019 Jun;41(3):630-666
pubmed: 30963447
PLoS One. 2009;4(2):e4439
pubmed: 19209224
Int J Clin Pharm. 2014 Oct;36(5):896-903
pubmed: 25135803
Am J Health Syst Pharm. 2020 Jan 24;77(3):222-232
pubmed: 31834928
Crit Care. 2021 Aug 31;25(1):322
pubmed: 34465357
Am J Health Syst Pharm. 2006 Nov 1;63(21):2116-22
pubmed: 17057049
J Am Soc Nephrol. 2012 Oct;23(10):1631-4
pubmed: 22935483
Curr Pharm Des. 2004;10(31):3931-46
pubmed: 15579081
J Clin Med. 2021 Apr 20;10(8):
pubmed: 33924036
BMC Cardiovasc Disord. 2017 Jan 21;17(1):39
pubmed: 28109266
Nephrol Dial Transplant. 2014 Aug;29(8):1597-607
pubmed: 24914089
Pharmacotherapy. 2018 Mar;38(3):309-318
pubmed: 29331037
Drugs Real World Outcomes. 2016 Sep;3(3):241-263
pubmed: 27747829
Res Social Adm Pharm. 2010 Sep;6(3):185-95
pubmed: 20813332
Int J Environ Res Public Health. 2022 Sep 06;19(18):
pubmed: 36141441
Transplant Proc. 2018 Oct;50(8):2451-2456
pubmed: 30316377
Kidney Int. 2006 Jun;69(11):1945-53
pubmed: 16641930
Clin Transplant. 2014 Jan;28(1):96-104
pubmed: 24329814
Pharmacotherapy. 2006 Jun;26(6):735-47
pubmed: 16716127
Med Care. 2010 Oct;48(10):923-33
pubmed: 20720510